Looking to expand your partner network with leading companies like Bone Therapeutics? Consider joining Inpart's global network for free.
News and Trends 7 Nov 2018
Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease
Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little hope of success for patients with the bone disease osteonecrosis. If all had gone as planned, the full trial would have monitored 118 patients over 24 months. However, an interim analysis on 44 patients after 12 months found little evidence […]